SEA-PAP High Oscillation Continuous Positive Airway Pressure Device

NeoRest team at the Seattle Children's Hospital

The Seattle Children’s Hospital High Oscillation Continuous Positive Airway Pressure (Sea-PAP) Device is a respiratory support technology for infants. The NeoRest Team claims that Sea-PAP improves upon conventional bCPAP by more consistently producing a range of oscillations thought to improve lung function and make it easier for an infant to breathe.

Product description

The Seattle Children’s Hospital High Oscillation Continuous Positive Airway Pressure (Sea-PAP) Device is a respiratory support technology for infants. The NeoRest Team claims that Sea-PAP improves upon conventional bCPAP by more consistently producing a range of oscillations thought to improve lung function and make it easier for an infant to breathe.

Target region(s)

Resource-limited countries, especially countries in Africa, Asia and South America.

Distributors/implementing organizations

The NeoRest Team is in the process of finalizing the Sea-PAP device design, identifying manufacturers to produce the device and preparing to conduct clinical trials. It is not being distributed widely at this time.

Market suggested retail price

Prototype. No pricing information yet available.

Competitive landscape

Infant ventilators, such as those from Heyer Medical AG, Hamilton Medical. Pumani bCPAP

SDG targeted

Goal 3: to improve and promote good health.

Decrease in neonatal mortality related to respiratory distress syndrome.

Target user(s)
The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F